| 941 | THORNTON, EILEENBUFFALO GROVE, IL · 60089 | MARKETING & SALES EXECUTIVE · GLAXOSMITHKLINE | ALEXANDRIA OCASIO-CORTEZ FOR CONGRESSC00639591 | 2026-01-08 | $15 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1963942FEC filing ↗ |
| 942 | DEMELIA, HEATHERNORTH ATTLEBORO, MA | CLINICAL RESEARCH ASSOCIATE · GLAXOSMITHKLINE | EMILYS LISTC00193433 | 2025-12-24 | $15 | Primary (P) | Filing 1934797FEC filing ↗ |
| 943 | CHERRY, DENNISROCKY MOUNT, NC · 27801 | MAINTENANCE MECHANIC · GLAXOSMITHKLINE | DCCCC00000935 | 2025-12-23 | $15 | Primary (P) | * EARMARKED CONTRIBUTION THROUGH ACTBLUE PAC ON 12/23/2025Filing 1940622FEC filing ↗ |
| 944 | DUNLEAVY, DONNADOWNINGTOWN, PA · 19335 | BIOCHEMIST · GLAXOSMITHKLINE | DCCCC00000935 | 2025-12-21 | $15 | Primary (P) | * EARMARKED CONTRIBUTION THROUGH ACTBLUE PAC ON 12/21/2025Filing 1940622FEC filing ↗ |
| 945 | HALL, DENISE C.PHILADELPHIA, PA · 19112 | E-DISCOVERY PROCESS PARTNER · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $15 | Primary (P) | Filing 1937874FEC filing ↗ |
| 946 | PARKER, DEBRA D.DURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT RESP BIOLOGICS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $15 | Primary (P) | Filing 1937874FEC filing ↗ |
| 947 | LOUGHLIN, CATHERINEDURHAM, NC · 27701 | VICE PRESIDENT, US SPECIALTY AND ONCOL · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $15 | Primary (P) | Filing 1937874FEC filing ↗ |
| 948 | NIJINSKY, SONYA ALEXANDRA MOIRAPHILADELPHIA, PA · 19112 | INTERNAL QUALITY AUDIT · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $15 | Primary (P) | Filing 1937874FEC filing ↗ |
| 949 | CRUZ, CHRISTIAN OMARWASHINGTON, DC · 20004 | PUBLIC POLICY · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $15 | Primary (P) | Filing 1937874FEC filing ↗ |
| 950 | BERGEY, AMANDA SCHROEDERPHILADELPHIA, PA · 19112 | PRODUCT STRATEGY & DEVELOPMENT · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $15 | Primary (P) | Filing 1937874FEC filing ↗ |
| 951 | CARDELLI, PAULDURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT ONCOLOGY · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $15 | Primary (P) | Filing 1937874FEC filing ↗ |
| 952 | NEILSON, NICHOLAS JAMESDURHAM, NC · 27709 | PRICING/REIMBURSEMENT - NICHOLAS NEILS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $15 | Primary (P) | Filing 1937874FEC filing ↗ |
| 953 | ANDERSON, CHARLES ALLENDURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT RESP BIOLOGICS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $15 | Primary (P) | Filing 1937874FEC filing ↗ |
| 954 | BROWN, BRENT WILLIAM GEORGEDURHAM, NC · 27709 | SALES FORCE EFFECTIVENESS (ONCOLOGY) · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $15 | Primary (P) | Filing 1937874FEC filing ↗ |
| 955 | GALLAGHER, RUSTINDURHAM, NC · 27709 | VACCINE STRATEGIC ACCT LEAD · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $15 | Primary (P) | Filing 1937874FEC filing ↗ |
| 956 | JOHNSON, KATHLEEN CASEYDURHAM, NC · 27709 | REGIONAL ACCOUNT EXECUTIVE · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $15 | Primary (P) | Filing 1937874FEC filing ↗ |
| 957 | GALLOWAY, BIJALDURHAM, NC · 27701 | SENIOR GLOBAL MARKETING DIRECTOR · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $15 | Primary (P) | Filing 1937874FEC filing ↗ |
| 958 | FURUYA, CHRIS A.DURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT RESP BIOLOGICS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $15 | Primary (P) | Filing 1937874FEC filing ↗ |
| 959 | HASELWANDER, MARK ADURHAM, NC · 27709 | VACCINE ACCT EXECUTIVE · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $15 | Primary (P) | Filing 1937874FEC filing ↗ |
| 960 | PAPANICKOLAS, YVONNE MARIEDURHAM, NC · 27709 | SR SALES SPEC, PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-12-19 | $15 | Primary (P) | Filing 1937874FEC filing ↗ |